Latest News and Press Releases
Want to stay updated on the latest news?
-
To Nasdaq Copenhagen 8 January 2026 FIXING OF COUPON RATES Fixing of coupon rates effective from 12 January 2026 Effective from 12 January 2026, the coupon rates of floating-rate bonds...
-
DENVER, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported...
-
Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ONAR Holding Corporation (OTCQB: ONAR) (“ONAR” or the “Company”), an AI-powered marketing platform that acquires and scales specialist agencies, today...
-
Grace E. Colón, Ph.D., Appointed Chair of the Board of Directors John Glasspool Appointed Board Director Lekhan Shivashankar Appointed Chief of Staff New Additions Strengthen Aronora as it Advances...
-
LONDON and MILAN, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced...
-
Transpire Bio CEO Dr. Xian-Ming Zeng will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2026
-
SAN MATEO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional...
-
Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026 Topline Results from North American Phase 3 C-BEYOND Trial Expected Mid-2026; Results from C-FORWARD...
-
Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing data Company to complete monotherapy expansion cohorts to determine...
-
First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in budoprutug Phase 1b/2a trial in ITP and Phase 1b trial in SLE; achieved...
-
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that it will...
-
Octopus AIM VCT plc Net Asset Value Octopus AIM VCT plc announces that as at 5 January 2026 the unaudited net asset value of the Ordinary shares was approximately 47 pence per share. The net asset...
-
Boehringer Ingelheim exercises option to license additional Dark Antigens from a wider array of tumor types, expanding Enara’s eligibility for milestone payments under existing collaboration Scott...
-
Octopus AIM VCT 2 plc Net Asset Value Octopus AIM VCT 2 plc announces that as at 5 January 2026 the unaudited net asset value of the Ordinary shares was approximately 37.3 pence per share. For...
-
PHOENIX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today...
-
BitMEX today released its end-of-year research report outlining five core insights that defined a turbulent year for the global crypto derivatives market.
-
Total Net Revenue Expected in the Range of $1,125 million to $1,195 millionTotal SUBLOCADE® Net Revenue Expected to be in the Range of $905 million to $945 millionNon-GAAP Operating Expenses Expected...
-
CMR Surgical receives CE Mark for use of Versius in paediatric surgery Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026,...
-
Combination of AT7687 and cagrilintide demonstrated enhanced weight loss effect in obese, insulin-resistant, pre-diabetic non-human primate (NHP) modelAdditional weight loss observed in combination...
-
Tisento's global Phase 2b PRIZM study, which is evaluating zagociguat for the treatment of the rare mitochondrial disease MELAS, is fully enrolled
-
MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Troilus Mining Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5) (“Troilus” or the “Company”), is pleased to provide a review of its key accomplishments in 2025...
-
DUBAI, United Arab Emirates, Jan. 08, 2026 (GLOBE NEWSWIRE) -- In Crypto Market, the projects that tend to break out are not always the loudest ones. They are the ones that keep shipping, keep...
-
Video Processing Platform Market Size & Segmentation By Component, Deployment Type, Application/Use Case, End-Use/Vertical, Region & Global Forecast
-
AtaiBeckley provides its outlook for 2026 ahead of attendance at the J.P. Morgan 44th Annual Healthcare Conference
-
SHENZHEN, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services...
-
VarmX and Rentschler Biopharma expand collaboration from early development to late‑stage and commercial manufacturing of VMX-C001VMX‑C001 builds on strong regulatory momentum, including FDA Fast Track...
-
TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX: K; NYSE: KGC) (“Kinross”) will provide an update on its Round Mountain Phase X, Kettle River-Curlew and Bald Mountain...
-
67% of additional patients (n=6) enrolled in the BEACON study achieved a complete response at 12 weeks with a mean UAS7 reduction of 31 points 75% of CSU participants (n=36) enrolled in the open...
-
VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that work has commenced on the recently acquired Pico...
-
Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy
-
Entrada Therapeutics reports progress across its portfolio of RNA-based programs for the potential treatment of neuromuscular and ocular diseases.
-
Round led by new investor Life Sciences at Goldman Sachs Alternatives with participation by new investor the Retinal Degeneration Fund, and supported by existing investorsFunds will advance laru-zova...
-
GlycoEra Appoints Petra Duda, M.D., Ph.D., as Chief Medical Officer to Advance Precision Immune Degrader Pipeline
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Bioenergy Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The bioenergy market report...
-
TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX: FURY, NYSE American: FURY) (“Fury” or the “Company”) is pleased to provide a review of 2025 corporate and technical...
-
Madrid, 8th January.- Spanish technology services company Lleida.net (BME:LLN) (EPA:ALLLN) began 2026 with a total of 8,886 active clients, representing a 55.62% increase compared with 5,710 clients...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Biological Crop Protection Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Aircraft Insulation Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The global aircraft...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Cast Aluminum Automotive Parts Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The cast aluminum automotive parts...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Microtome Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The microtome market report...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) Visual Inspection System Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's...
-
RentRedi received the NAR REALTOR Benefits® Customer Experience Award for delivering long-term value to real estate agents navigating rental investing.
-
VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports full year 2025 production of 6,486,661 silver...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Algae Products Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The global algae products...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Asphalt and Concrete Equipment Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Circular Economy Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The circular economy...
-
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. today announced it will host its fourth quarter and full year 2025 conference call and webcast on Wednesday, February 4,...
-
DAYTONA BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and Jack Brubaker and L. Allan Boyd, owners of Shoemaker...
-
Summit Provides 2025 Corporate Update and Upcoming 2026 Catalysts
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Employment Services Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The global...